FDA approves gardenia-derived blue dye for food and drinks, offering a safer, plant-based alternative to synthetic colors.

Diagnos Inc. (“DIAGNOS” or the “Corporation”) (TSX Venture: ADK, OTCQB: DGNOF, FWB: 4D4A), a Canadian leader in artificial intelligence (AI) for the ...

Silo Pharma, Inc. (Nasdaq: SILO) ('Silo” or the 'Company”), a developmental stage biopharmaceutical company focused on novel therapeutics and drug delivery systems, today announced completion of ...

GC Biopharma USA, Inc., a leader in plasma-derived products, announced the presentation of new data on the viscosity of several commercially available 10% intravenous immunoglobulin (IVIG) products at ...

Health Secretary Robert F. Kennedy Jr. and other Trump officials are signaling their interest in approving psychedelic drugs for hard-to-treat mental health conditions. It's a goal long sought ...

Highest Rated Children’s Medical Centers Now Employ QUELIMMUNE for Ultra-Rare Cases of Pediatric AKI HDE Surveillance Registry Data Captures Key Metrics for Future Analysis of QUELIMMUNE Performance ...

SHELTON, CONNECTICUT / ACCESS Newswire / July 16, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) ...

The agricultural industry is lobbying for the continued use of pesticides in crop production following a Make America Healthy Again (MAHA) report.

The warning reflects growing concern over a surge in opioid products marketed to US consumers containing concentrated levels of 7-hydroxymitragynine (7-OH).

Hims & Hers Health partnered with Novo Nordisk earlier this year, only for that to unravel shortly afterward due to ...

The extended patent protection strengthens Madrigal’s market position by preventing generic competition for over two decades, potentially securing long-term revenue streams for the biopharmaceutical ...

New data shows no increased cardiovascular risk of the osteoporosis drug vs anabolic agents — and even suggests a lower risk.